Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 03, 2025 08:30 ET | Source: PharmAla Biotech

PharmAla Files Final Base Shelf Prospectus and Signs Term Sheet with Radium Capital

PharmAla files its final short form prospectus, and announces a signed term sheet with an R&D tax credit financing firm called Radium
October 30, 2025 04:30 ET | Source: Oculis Holding AG

Oculis Announces Oversubscribed $110 Million Financing to Accelerate Privosegtor Development

ZUG, Switzerland, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis” or the “Company”), a global biopharmaceutical company focused on breakthrough innovations to...
October 29, 2025 07:00 ET | Source: Evergold Corp.

Evergold Announces $350,000 Non-Brokered Convertible Debenture Private Placement with CJ Greig to Finance Drilling in Early November at the DEM Gold Prospect

Evergold Announces $350,000 Private Placement with CJ Greig to Finance Drilling in Early November at the DEM Gold Prospect, BC
October 28, 2025 10:30 ET | Source: Alterra IOS

Alterra IOS Announces Close of $150M Loan Commitment from Funds Managed by Blue Owl Capital Inc.

PHILADELPHIA, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Alterra IOS (“Alterra”), a prominent player in the industrial outdoor storage (“IOS”) sector that has acquired over 400 sites nationwide, today...
October 22, 2025 11:00 ET | Source: TASI Bank

TASI® Bank Closes Two Financing Transactions With Sonesta-branded Hotels

SAN FRANCISCO, Oct. 22, 2025 (GLOBE NEWSWIRE) -- TASI® Bank (www.tasi.bank), a San Francisco–based community business bank, today announced it has provided a total of $26.15 million in purchase...
October 22, 2025 04:00 ET | Source: smartbax GmbH

smartbax announces a €4.7 M Pre-Series A round to advance novel antibiotic compound through preclinical stage

Lead antibacterial compound against a novel target in Gram-negative bacteria validated in infection modelsProgressing a platform of small-molecule enzymatic activators that induce self-digestion...
October 21, 2025 13:20 ET | Source: Talonvest Capital, Inc.

Talonvest Secures $205.2 M in Financings for Etude Storage Portfolios

NEWPORT BEACH, Calif., Oct. 21, 2025 (GLOBE NEWSWIRE) -- On behalf of Etude Capital and its affiliates, Talonvest Capital, Inc., a boutique commercial real estate mortgage brokerage firm, is pleased...
October 21, 2025 08:00 ET | Source: Minerva Neurosciences, Inc

Minerva Neurosciences Announces Financing of up to $200 Million to Advance Roluperidone for the Treatment of Negative Symptoms in Patients with Schizophrenia Through a Phase 3 Confirmatory Trial and Resubmission of its New Drug Application and Preparation for US Commercial Launch, if Approved

Minerva Neurosciences Announces Financing of up to $200M to Advance Roluperidone for the Treatment of Negative Symptoms in Patients with Schizophrenia
October 20, 2025 19:09 ET | Source: VR Resources Ltd.

VR Resources Announces $1.5M Brokered Private Placement Led by Centurion One Capital, Concurrent Share Consolidation, Management Change, and Start-Up of Drill Planning for its New Boston Tungsten-Molybdenum-Copper-Silver porphyry project in Nevada

VR Resources Announces $1.5M Brokered Private Placement, Concurrent Share Consolidation, Management Change, and Drill Planning at New Boston
October 20, 2025 18:15 ET | Source: Abaxx Technologies Inc.

Abaxx Announces Closing of US$22 Million Strategic Financing

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ TORONTO, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Abaxx Technologies Inc. (CBOE:ABXX) (“Abaxx” or the...